Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 25641895.
- Also identified by DOI 10.3899/jrheum.141164 and PMC identifier 4966884.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The gout working group at the Outcome Measures in Rheumatology (OMERACT) 12 meeting in 2014 aimed to determine which imaging modalities show the most promise for use as measurement instruments for outcomes in studies of people with chronic gout and to identify the key foci for future research about the performance of these imaging techniques with respect to the OMERACT filter 2.0. During the gout session, a systematic literature review of the data addressing imaging modalities including plain radiography (XR), conventional computed tomography (CT), dual-energy computed tomography (DECT), magnetic resonance imaging (MRI), and ultrasound (US) and the fulfillment of the OMERACT filter 2.0 was presented. The working group identified 3 relevant domains for imaging in gout studies: urate deposition (tophus burden), joint inflammation, and structural joint damage. The working group prioritized gaps in the data and identified a research agenda.
Medical subject headings
- Diagnostic Imaging
- Gout
- Outcome Assessment, Health Care
- Practice Guidelines as Topic
- Uric Acid